LunarLock 7-Year review

Yes, for the right buyer. If you want a locked rate, a seven-year commitment does not scare you, and you are comfortable with a less-known carrier backed by an A-rated entity, LunarLock 7-Year does what it promises. It is not the right product if you want index upside, income guarantees, or the reassurance of a household-name insurance company.

The primary reason is a guaranteed rate locked for seven years with no moving parts. For a buyer who is done with uncertainty — no market exposure, no crediting-strategy decisions, no rider fee math — a MYGA at a competitive rate is a clean answer. The secondary reason is the nursing home rider and the full account value death benefit, which reduce the practical risk of locking money up for seven years if health circumstances change.

I think LunarLock 7-Year is best for someone in their mid-50s to mid-70s who has a defined chunk of non-qualified or IRA money they do not expect to touch for the full term, wants certainty over growth potential, and is comfortable doing a little carrier research to capture a rate advantage over better-known names. The wide issue-age window (18–88) is worth noting — the product can accommodate older purchasers who still have a realistic seven-year horizon. It is less attractive for someone who wants any flexibility to redirect funds, someone whose primary goal is income, or someone who puts strong weight on carrier brand recognition.

A MYGA is not an investment. It is an insurance product that functions like a time deposit: you hand over a lump sum, the company credits a stated rate for a fixed number of years, and you get the accumulated value back at maturity — tax-deferred. LunarLock 7-Year adds a small amount of texture via the nursing home rider and the free-withdrawal provision, but the core mechanics are simple. What you are exchanging is liquidity for certainty. The rate is guaranteed the day you sign; the surrender penalty and MVA are the price of that guarantee if you change your mind.

AuguStar credits a single fixed interest rate to your account value for the full seven-year term. The rate is set at issue and does not change — it does not depend on index performance, no cap or participation rate applies, and there is no annual reset. As of April 2026, AuguStar was quoting 5.00% for premiums below $100,000 and 5.20% for $100,000 or more. The guaranteed minimum interest rate (GMIR) is 0.25%, meaning the company has a contractual floor even in a world where its renewal rates deteriorate. Because this is a single-premium product, you put money in once and the rate applies to the full amount from day one.

The nursing home rider is the most practically meaningful add-on here. If you are confined to a nursing home after the first contract year, AuguStar waives surrender charges on distributions, which removes what is otherwise a meaningful constraint on a seven-year commitment. That matters because the primary buyers of a seven-year MYGA are typically pre-retirees or early retirees, and health uncertainty is a real concern over that timeframe. The full account value death benefit is also worth noting: your beneficiaries receive the accumulated contract value, not a reduced surrender value.

LunarLock 7-Year is a seven-year commitment and should be treated as one. The free-withdrawal provision gives you access to 10% of premiums in year one and 10% of the prior anniversary value in subsequent years without penalty — useful for RMDs and modest income needs, but not a substitute for short-term liquidity. Amounts above the free-withdrawal corridor are subject to the surrender charge schedule below, and an MVA — Market Value Adjustment — also applies. The MVA means your effective exit cost is not just the stated charge; it can increase or decrease depending on interest rate conditions at the time of withdrawal. In a rising-rate environment, the MVA works against you.

The contract becomes fully liquid after year seven. Note that year eight shows 0% — the product runs through the end of the surrender period before full liquidity kicks in.

There are no explicit product fees on LunarLock 7-Year. No base contract charge, no rider fee (no income rider is offered), no annual administration fee disclosed in the available materials. The cost of this product is entirely structural: you are earning the stated rate because you have agreed to leave the money in place. The spread the carrier earns is embedded in the rate they offer, not charged back to you as a fee line.

The meaningful tradeoffs are the duration, the MVA, and the carrier profile. Seven years is longer than the median MYGA term in the market. The MVA adds interest-rate sensitivity that a plain surrender schedule does not have. And AuguStar is a less-recognized name — the A rating from A.M. Best is a reasonable marker, but the company lacks the track record and brand depth of carriers that have been issuing annuities for decades.

Legal Entity: AuguStar Life Insurance Company

Parent: Constellation Insurance

A.M. Best Rating: A